(PRLB) Proto Labs - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7437131094
PRLB: Injection Molding, CNC Machining, 3D Printing, Sheet Metal Fabrication
Proto Labs Inc (NYSE:PRLB) stands as a leader in the realm of digital manufacturing, specializing in the rapid production of custom parts. Their expertise spans injection molding, CNC machining, 3D printing, and sheet metal fabrication, catering to a diverse clientele of engineers and developers. By leveraging cutting-edge technology and a customer-centric approach, Proto Labs streamlines the manufacturing process, enabling quick turnaround times and precise execution.
Founded in 1999 and headquartered in Maple Plain, Minnesota, Proto Labs has established itself as a pivotal player in the industry, serving a broad spectrum of markets. Their services are integral to product development cycles, offering a scalable model that accommodates both prototyping and production needs. This versatility underscores their appeal to a wide range of industries, from medical devices to consumer goods.
From a financial perspective, Proto Labs presents an intriguing profile for investors. With a market capitalization of approximately $1.1 billion, the company demonstrates a robust presence in the market. The current P/E ratio of 68.23 and forward P/E of 24.69 suggest a blend of current valuation and future growth potential. The P/B ratio of 1.60 and P/S ratio of 2.19 provide further insight into their financial health and operational efficiency.
For investors and fund managers, Proto Labs commitment to innovation and operational excellence positions it as a compelling opportunity. Their ability to integrate advanced manufacturing technologies with a responsive customer service model highlights their strategic advantage. As the manufacturing sector continues to evolve, Proto Labs scalable digital platform and diverse service offerings place it at the forefront of this transformation, making it a noteworthy candidate for investment consideration.
Additional Sources for PRLB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PRLB Stock Overview
Market Cap in USD | 901m |
Sector | Industrials |
Industry | Metal Fabrication |
GiC Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception | 2012-02-24 |
PRLB Stock Ratings
Growth 5y | -36.7% |
Fundamental | 7.74% |
Dividend | 0.0% |
Rel. Strength Industry | -1.29 |
Analysts | 3.8/5 |
Fair Price Momentum | 30.36 USD |
Fair Price DCF | 40.59 USD |
PRLB Dividends
No Dividends PaidPRLB Growth Ratios
Growth Correlation 3m | -24.9% |
Growth Correlation 12m | 47.5% |
Growth Correlation 5y | -80.5% |
CAGR 5y | -11.16% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | -0.06 |
Alpha | -4.02 |
Beta | 1.15 |
Volatility | 41.21% |
Current Volume | 150.9k |
Average Volume 20d | 217.2k |
As of March 16, 2025, the stock is trading at USD 36.55 with a total of 150,898 shares traded.
Over the past week, the price has changed by -3.82%, over one month by -17.27%, over three months by -18.36% and over the past year by +7.66%.
Neither. Based on ValueRay Fundamental Analyses, Proto Labs is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.74 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRLB as of March 2025 is 30.36. This means that PRLB is currently overvalued and has a potential downside of -16.94%.
Proto Labs has received a consensus analysts rating of 3.80. Therefor, it is recommend to hold PRLB.
- Strong Buy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PRLB Proto Labs will be worth about 34 in March 2026. The stock is currently trading at 36.55. This means that the stock has a potential downside of -7.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 44.3 | 21.3% |
Analysts Target Price | 40.3 | 10.3% |
ValueRay Target Price | 34 | -7% |